Because IBD patients had rapidly proliferating, activated CD4+ T lymphocytes with downregulated CARS2 expression and because human T cell proliferation was inhibited by GSSSG treatment (Figure 6), our data strongly suggest that supersulfide metabolic pathway is functional in human CD4+ T lymphocytes as well. Here, CARS2 is linked to inflammatory bowel disease.